The predictive impact of hematological inflammatory markers in detecting prostate cancer in patients with PI-RADS 3 lesions on multiparametric magnetic resonance imaging.
Rıdvan KayarEmre TokucEmrah ÖzsoySamet DemirKemal KayarRamazan TopaktaSelamettin DemirMetin İshak ÖztürkPublished in: The Prostate (2024)
SIRI outperformed NLR and PIV in detecting PCa in PI-RADS 3 lesions, showcasing its potential as a valuable biomarker. Implementation of this parameter to possible future nomograms has the potential to individualize and risk-stratify the patients in prostate biopsy decision.